Clinical Outcomes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections with Susceptibilities among Levofloxacin, Cefepime, and Carbapenems
Purpose. Highly resistant Gram-negative bacterial infections are associated with high mortality. Increasing resistance to standard therapy illustrates the need for alternatives when treating resistant organisms, especially extended-spectrum beta-lactamase- (ESBL-) producing Enterobacteriaceae. Metho...
Saved in:
| Main Authors: | Kristy J. Walker, Young R. Lee, Amanda R. Klar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2018/3747521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genotypes and cephalosporin susceptibility in extended-spectrum beta-lactamase producing enterobacteriaceae in the community
by: Daniel Maina, et al.
Published: (2011-11-01) -
Predictors of mortality from extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia
by: Hiroki Namikawa, et al.
Published: (2023-12-01) -
Risk factors for the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospitalized children
by: Luciana Robino, et al.
Published: (2013-04-01) -
Molecular Genetic Typing of Enterobacteriaceae Producing an Extended Spectrum Beta-Lactamase in Patients with Hemoblastoses
by: A. G. Korobova, et al.
Published: (2020-05-01) -
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections
by: Ayhanim Tumturk, et al.
Published: (2019-01-01)